Global Selective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Selective Agonists Market Overview

• 1.1 Product Overview and Scope of Selective Agonists
• 1.2 Classification of Selective Agonists by Types
  • 1.2.1 Global Selective Agonists Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Selective Agonists Revenue Market Share by Types in 2018
  • 1.2.3 α1 Selective Agonists
  • 1.2.4 α2 Selective Agonists
  • 1.2.5 β1 Selective Agonists
  • 1.2.6 β2 Selective Agonists
• 1.3 Global Selective Agonists Market by Application
  • 1.3.1 Global Selective Agonists Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Paroxysmal Supraventricular Tachycardia
  • 1.3.3 Eye Drops
  • 1.3.4 Anaphylaxis
  • 1.3.5 Cardiac Arrest
  • 1.3.6 Anaphylaxis
  • 1.3.7 Cardiac Arrest
  • 1.3.8 Chronic Heart Failure
  • 1.3.9 Myocardial Infarction
  • 1.3.10 Postoperative Hypotension
• 1.4 Global Selective Agonists Market by Regions
  • 1.4.1 Global Selective Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Selective Agonists Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Selective Agonists Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Selective Agonists Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Selective Agonists Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Selective Agonists Status and Prospect (2014-2024)
• 1.5 Global Market Size of Selective Agonists (2014-2024)

2 Manufacturers Profiles

• 2.1 Merck
  • 2.1.1 Business Overview
  • 2.1.2 Selective Agonists Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Merck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Bausch Health Companies
  • 2.2.1 Business Overview
  • 2.2.2 Selective Agonists Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Bausch Health Companies Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Selective Agonists Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Pfizer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Sterling Winthrop
  • 2.4.1 Business Overview
  • 2.4.2 Selective Agonists Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Sterling Winthrop Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Sanofi
  • 2.5.1 Business Overview
  • 2.5.2 Selective Agonists Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Sanofi Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Paragon BioTeck
  • 2.6.1 Business Overview
  • 2.6.2 Selective Agonists Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Paragon BioTeck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 West-Ward Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Selective Agonists Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 West-Ward Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Biosyent Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Selective Agonists Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Biosyent Pharma Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Novartis
  • 2.9.1 Business Overview
  • 2.9.2 Selective Agonists Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Novartis Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Omega Laboratories
  • 2.10.1 Business Overview
  • 2.10.2 Selective Agonists Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Omega Laboratories Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Medical Purchasing Solutions
  • 2.11.1 Business Overview
  • 2.11.2 Selective Agonists Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Medical Purchasing Solutions Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Avadel Legacy Pharmaceuticals
  • 2.12.1 Business Overview
  • 2.12.2 Selective Agonists Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Avadel Legacy Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Amneal Biosciences
  • 2.13.1 Business Overview
  • 2.13.2 Selective Agonists Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Amneal Biosciences Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Cipla USA
  • 2.14.1 Business Overview
  • 2.14.2 Selective Agonists Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Cipla USA Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Par Pharmaceutical
  • 2.15.1 Business Overview
  • 2.15.2 Selective Agonists Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Par Pharmaceutical Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Glaxosmithkline
  • 2.16.1 Business Overview
  • 2.16.2 Selective Agonists Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Glaxosmithkline Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Teva
  • 2.17.1 Business Overview
  • 2.17.2 Selective Agonists Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Teva Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Bayer
  • 2.18.1 Business Overview
  • 2.18.2 Selective Agonists Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Bayer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Impax Generics
  • 2.19.1 Business Overview
  • 2.19.2 Selective Agonists Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Impax Generics Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Mylan Pharmaceuticals
  • 2.20.1 Business Overview
  • 2.20.2 Selective Agonists Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Mylan Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Physicians Total Care
  • 2.21.1 Business Overview
  • 2.2.2 Selective Agonists Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Physicians Total Care Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Cadila Pharnmaceuticals
  • 2.22.1 Business Overview
  • 2.22.2 Selective Agonists Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Cadila Pharnmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Alembic Pharmaceuticals
  • 2.23.1 Business Overview
  • 2.23.2 Selective Agonists Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Alembic Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.24 Allergan
  • 2.24.1 Business Overview
  • 2.24.2 Selective Agonists Type and Applications
    • 2.24.2.1 Product A
    • 2.24.2.2 Product B
  • 2.24.3 Allergan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.25 Mylan
  • 2.25.1 Business Overview
  • 2.25.2 Selective Agonists Type and Applications
    • 2.25.2.1 Product A
    • 2.25.2.2 Product B
  • 2.25.3 Mylan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)

3 Global Selective Agonists Market Competition, by Players

• 3.1 Global Selective Agonists Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Selective Agonists Players Market Share
  • 3.2.2 Top 10 Selective Agonists Players Market Share
• 3.3 Market Competition Trend

4 Global Selective Agonists Market Size by Regions

• 4.1 Global Selective Agonists Revenue and Market Share by Regions
• 4.2 North America Selective Agonists Revenue and Growth Rate (2014-2019)
• 4.3 Europe Selective Agonists Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Selective Agonists Revenue and Growth Rate (2014-2019)
• 4.5 South America Selective Agonists Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Selective Agonists Revenue and Growth Rate (2014-2019)

5 North America Selective Agonists Revenue by Countries

• 5.1 North America Selective Agonists Revenue by Countries (2014-2019)
• 5.2 USA Selective Agonists Revenue and Growth Rate (2014-2019)
• 5.3 Canada Selective Agonists Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Selective Agonists Revenue and Growth Rate (2014-2019)

6 Europe Selective Agonists Revenue by Countries

• 6.1 Europe Selective Agonists Revenue by Countries (2014-2019)
• 6.2 Germany Selective Agonists Revenue and Growth Rate (2014-2019)
• 6.3 UK Selective Agonists Revenue and Growth Rate (2014-2019)
• 6.4 France Selective Agonists Revenue and Growth Rate (2014-2019)
• 6.5 Russia Selective Agonists Revenue and Growth Rate (2014-2019)
• 6.6 Italy Selective Agonists Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Selective Agonists Revenue by Countries

• 7.1 Asia-Pacific Selective Agonists Revenue by Countries (2014-2019)
• 7.2 China Selective Agonists Revenue and Growth Rate (2014-2019)
• 7.3 Japan Selective Agonists Revenue and Growth Rate (2014-2019)
• 7.4 Korea Selective Agonists Revenue and Growth Rate (2014-2019)
• 7.5 India Selective Agonists Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Selective Agonists Revenue and Growth Rate (2014-2019)

8 South America Selective Agonists Revenue by Countries

• 8.1 South America Selective Agonists Revenue by Countries (2014-2019)
• 8.2 Brazil Selective Agonists Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Selective Agonists Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Selective Agonists Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Selective Agonists by Countries

• 9.1 Middle East and Africa Selective Agonists Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Selective Agonists Revenue and Growth Rate (2014-2019)
• 9.3 UAE Selective Agonists Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Selective Agonists Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Selective Agonists Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Selective Agonists Revenue and Growth Rate (2014-2019)

10 Global Selective Agonists Market Segment by Type

• 10.1 Global Selective Agonists Revenue and Market Share by Type (2014-2019)
• 10.2 Global Selective Agonists Market Forecast by Type (2019-2024)
• 10.3 α1 Selective Agonists Revenue Growth Rate (2014-2024)
• 10.4 α2 Selective Agonists Revenue Growth Rate (2014-2024)
• 10.5 β1 Selective Agonists Revenue Growth Rate (2014-2024)
• 10.6 β2 Selective Agonists Revenue Growth Rate (2014-2024)

11 Global Selective Agonists Market Segment by Application

• 11.1 Global Selective Agonists Revenue Market Share by Application (2014-2019)
• 11.2 Selective Agonists Market Forecast by Application (2019-2024)
• 11.3 Paroxysmal Supraventricular Tachycardia Revenue Growth (2014-2019)
• 11.4 Eye Drops Revenue Growth (2014-2019)
• 11.5 Anaphylaxis Revenue Growth (2014-2019)
• 11.6 Cardiac Arrest Revenue Growth (2014-2019)
• 11.7 Anaphylaxis Revenue Growth (2014-2019)
• 11.8 Cardiac Arrest Revenue Growth (2014-2019)
• 11.9 Chronic Heart Failure Revenue Growth (2014-2019)
• 11.10 Myocardial Infarction Revenue Growth (2014-2019)
• 11.11 Postoperative Hypotension Revenue Growth (2014-2019)

12 Global Selective Agonists Market Size Forecast (2019-2024)

• 12.1 Global Selective Agonists Market Size Forecast (2019-2024)
• 12.2 Global Selective Agonists Market Forecast by Regions (2019-2024)
• 12.3 North America Selective Agonists Revenue Market Forecast (2019-2024)
• 12.4 Europe Selective Agonists Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Selective Agonists Revenue Market Forecast (2019-2024)
• 12.6 South America Selective Agonists Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Selective Agonists Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology